Abstract
Background: Celiac disease pathogenesis involves increased permeability of intestinal epithelial tight junctions due to immunogenic mechanisms. Larazotide acetate is a tight junction regulator peptide that was recently described.
Cite
CITATION STYLE
APA
Moole, H. (2016). A systematic review and meta-analysis of randomized controlled trials: Efficacy and safety of larazotide acetate in celiac disease patients undergoing a gluten challenge. Journal of Gastroenterology, Pancreatology & Liver Disorders, 3(3), 01–08. https://doi.org/10.15226/2374-815x/3/3/00160
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free